News

News

JUVELOOK Celebrates One Million Vial Milestone

English
Author
Ju**************
Date
2025-01-23 16:15
Views
77


JUVELOOK Celebrates One Million Vial Milestone

VAIM GLOBAL celebrated a significant milestone on August 31, 2024, with the grand 'JUVELOOK ONE MILLION Vial CELEBRATION' at the Grand Hyatt Seoul.

The event served as a platform to share Juvelook's growth journey and future vision while expressing gratitude to over 90 esteemed medical professionals who contributed to Juvelook's success. The gathering focused on sharing insights and experiences with Juvelook, highlighting its unique features, safety, biocompatibility, and diverse applications. Additionally, VAIM GLOBAL presented the One Million Award to five medical professionals with the highest Juvelook usage, expressing gratitude for their trust and support.

A VAIM GLOBAL representative stated, " Juvelook's growth is driven by professional trust, and we aim to expand its applications with advanced technology to lead the medical aesthetics industry.



Introduction of VAIM
Founded in 2014, VAIM is a global medical aesthetics company that develops human tissue regeneration products and improved pharmaceuticals by utilizing its accumulated technology and know-how in biocompatible and biodegradable polymers. It has developed and patented a PDLLA-based manufacturing technology that reduces the risk of nodule formation compared to other ingredient structures, and in 2019, its subsidiary, VAIM Global, entered the skin booster market with JUVELOOK, which utilizes this technology. JUVELOOK is a collagen booster that induces the production of ECM (collagen, elastin) to provide direct remodeling effects on the skin such as elasticity and wrinkle improvement, and is divided into JUVELOOK and LENISNA depending on the purpose. After quickly proving its safety and effectiveness since its launch, VAIM Global currently has product export contracts with 72 countries.